IGMS
IGM Biosciences
IGMS
IGMS
Delisted
IGMS was delisted on the 13th of August, 2025.
81 hedge funds and large institutions have $1.02B invested in IGM Biosciences in 2020 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 38 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.89% more ownership
Funds ownership: 55% → 57.9% (+2.9%)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
81
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$19.7M | |
| 2 | +$17.7M | |
| 3 | +$16M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$9.96M |
| 5 |
BlackRock
New York
|
+$7.95M |
Top Sellers
| 1 | -$40.3M | |
| 2 | -$6.28M | |
| 3 | -$5.99M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$5.85M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$3.44M |